NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.

Thompson, John A; Schneider, Bryan J; Brahmer, Julie; Andrews, Stephanie; Armand, Philippe; Bhatia, Shailender; Budde, Lihua E; Costa, Luciano; Davies, Marianne; Dunnington, David; Ernstoff, Marc S; Frigault, Matthew; Kaffenberger, Benjamin H; Lunning, Matthew; McGettigan, Suzanne; McPherson, Jordan; Mohindra, Nisha A; Naidoo, Jarushka; Olszanski, Anthony J; Oluwole, Olalekan; Patel, Sandip P; Pennell, Nathan; Reddy, Sunil; Ryder, Mabel; Santomasso, Bianca; Shofer, Scott; Sosman, Jeffrey A; Wang, Yinghong; Weight, Ryan M; Johnson-Chilla, Alyse; Zuccarino-Catania, Griselda; Engh, Anita.
J Natl Compr Canc Netw; 18(3): 230-241, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-32135517